CA2761156C — Methods of preventing ischemic injury using peripheral nociceptive stimulation
Assigned to University of Cincinnati · Expires 2017-03-14 · 9y expired
What this patent protects
Methods of inhibiting ischemia-related and ischemia-reperfusion- related injury are provided. Remote administra-tion of a C-fiber activator or TRPV1 agonist or remote electrical stimulation and activation of TRPV1 reduces ischemia-related tissue damage in subjects at risk for Isc…
USPTO Abstract
Methods of inhibiting ischemia-related and ischemia-reperfusion- related injury are provided. Remote administra-tion of a C-fiber activator or TRPV1 agonist or remote electrical stimulation and activation of TRPV1 reduces ischemia-related tissue damage in subjects at risk for Ischemia-related tissue damage, in aspects of the invention, remote application of a TRPV1 agonist inhibits ischemia-related cardiac tissue damage. Methods of inhibiting cardiac tissue damage by topically administering the TRPV1 agonist, capsaicin are provided.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.